Physician profile

Alan Gerald Weintraub

Developmental - Behavioral Pediatrics · Norcross, GA

NPI 1447295431

$65,926.50

in general payments reported to CMS, 2019-2025

12 companies · none reported in 2025

See the full distribution for Developmental - Behavioral Pediatrics

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Ironshore Pharmaceuticals INC. $41,748.65 2019-2022
Corium, LLC $12,710.97 2021-2022
Supernus Pharmaceuticals, INC. $10,849.62 2021-2022
Tris Pharma INC $179.40 2019-2021
Neos Therapeutics, LP $87.96 2019-2021
Sunovion Pharmaceuticals INC. $86.72 2019-2021
Otsuka America Pharmaceutical, INC. $69.06 2019-2022
Adlon Therapeutics L.P. $51.76 2019-2021
Otsuka Pharmaceutical Development & Commercialization, INC. $44.67 2019-2021
Shire North American Group INC $36.46 2019
Lilly USA, LLC $31.29 2019
Takeda Pharmaceuticals U.S.A., INC. $29.94 2021-2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alan Gerald Weintraub

$65,926.50

in general payments reported 2019-2025

Years
2019-2022
Top company
Ironshore Pharmaceuticals INC.

https://glasscript.com/doctor/201084/alan-gerald-weintraub

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.